Effect of CB1-Antagonist (AM251) on Metabolic Syndrome (Prophylactic and Therapeutic)

Ahmed Mohammed Taha^1*, Elsayed Mohammed Tayee¹, Dalia Ali Gaber², Deaa Fekri Morsi³ and Abdelbaset Taher Abdelhalim⁴

¹Department of Clinical Pharmacology, Faculty of Medicine, Helwan University, Helwan, Egypt

²Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Helwan University, Helwan, Egypt

³Department of Pathology, Faculty of Medicine, Helwan University, Helwan, Egypt

⁴Department of Clinical Pharmacology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

^*Corresponding Author: Ahmed Mohammed Taha, Department of Clinical Pharmacology, Faculty of Medicine, Helwan University, Helwan, Egypt Email: